A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis

This publication has 10 references indexed in Scilit:

• Predictive Factors of Delayed Emesis in Cisplatin-Treated Patients and Antiemetic Activity and Tolerability of Metoclopramide or Dexamethasone
  American Journal of Clinical Oncology, 1991
• Methodology of antiemetic trials: A review
  Annals of Oncology, 1991
• Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
  Journal of Clinical Oncology, 1989
• Metoclopramide-Induced Movement Disorders
  Archives of internal medicine (1960), 1989
• Metoclopramide-induced movement disorders. Clinical findings with a review of the literature
  Archives of internal medicine (1960), 1989
• Chlorpromazine and Dexamethasone versus High-Dose Metoclopramide and Dexamethasone in Patients Receiving Cancer Chemotherapy, Particularly Cis-Platinum: A Prospective Randomized Crossover Study
  Oncology, 1989
• ARE WE MAKING PROGRESS IN THE MANAGEMENT OF CYTOTOXIC DRUG–INDUCED NAUSEA AND VOMITING?
  Journal of Clinical Pharmacy & Therapeutics, 1988
• Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis
  British Journal of Cancer, 1987
• The Management of Chemotherapy-Induced Nausea and Vomiting
  Medical Clinics of North America, 1987
• On the receiving end—patient perception of the side-effects of cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1983